Dec 17 (Reuters) - Drugmaker Pfizer Inc (NYSE:PFE) PFE.N will request for an approval of its COVID-19 vaccine in Japan on Friday, Kyodo News reported, citing sources familiar with the move.
The Japanese government has a supply deal with Pfizer for 120 million vaccine doses. (https:// United States and Britain have already begun administering the vaccine made by Pfizer and German partner BioNTech 22UAy.DE .